PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

First look at the full multiple myeloma genome reveals new insights, discoveries

Sequencing and analysis of nearly 40 tumor genomes points multiple myeloma research in new directions

2011-03-24
(Press-News.org) Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights into the events that lead to this form of cancer and could influence the direction of multiple myeloma research. This work, led by scientists at the Broad Institute and Dana-Farber Cancer Institute, appears in the March 24 issue of Nature.

Multiple myeloma is the second most common blood cancer in the United States and causes about 20,000 new cases in this country every year. The disease's five-year survival rate is less than 40 percent, which is low compared to other forms of cancer. Multiple myeloma begins in the bone marrow, where plasma cells (a type of white blood cell) become malignant, crowding out normal cells and attacking solid bone. No one knows the cause of the disease – it can develop in people with no known risk factors and in many cases, no family history of multiple myeloma.

The emerging genome-wide picture of multiple myeloma reveals genes never before associated with cancer as well as multiple genetic mutations that disrupt just a handful of common pathways, or chains of chemical reactions that trigger a change in a cell. Individually, each of these mutations is fairly uncommon and might have remained undiscovered had the researchers not looked at such a large collection of samples.

"Already, we can see that mutations are funneling into a limited number of pathways," said co-senior author Todd Golub, director of the Broad's Cancer Program and Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute. "This is a demonstration of the value of looking at more than just a single tumor at great depth."

Never before have scientists taken an in-depth look at so many multiple myeloma samples. Over the last six years, "next-generation" sequencing technologies – machines that can sequence DNA at a rapid pace and deliver massive amounts of data in a short period of time – have surged. Sequencing the full genome of a tumor is still a feat of technical and analytical prowess and only a few studies to date have looked across more than one. The team of researchers studied 38 multiple myeloma patients, comparing the patients' normal genomes to the genomes from their malignant cells.

With the whole cancer genome in view, one of the most challenging aspects of multiple myeloma research is now separating so called driving events – the important mistakes that drive cells toward becoming cancerous – from passenger mutations, genetic alterations that are merely along for the ride. A team of researchers led by co-senior author Gad Getz, director of Cancer Genome Analysis at the Broad Institute, has developed computational tools to address this.

"Next-generation sequencing has the great potential and promise to allow us to comprehensively analyze the cancer genome at extremely high resolution and see all of the events that happen in cancer," said Getz. "These tools that we've developed are state-of-the-art – we've been able to dramatically decrease the error rate for detecting all types of mutations. Now, we can find those genes whose mutations occur more than expected by chance."

The researchers found sets of mutations affecting many genes in the same pathways, including the NF-κB pathway. If this pathway is turned on at the wrong time, it can activate genes that allow a cancer cell to grow and divide unchecked. Previously, multiple myeloma researchers had suspected that this pathway was involved in the cancer's development, but it was unclear exactly what events were turning this pathway on. In this latest study, the researchers discovered 11 different genes involved in this pathway that were altered in at least one multiple myeloma sample.

Additionally, the study has brought to light new mutations affecting genes that had never previously been tied to cancer. "These genes, which are frequently mutated, were not on anyone's radar before when thinking about multiple myeloma specifically or cancer in general," said Golub, who is also an investigator at Howard Hughes Medical Institute, and professor of pediatrics at Harvard Medical School. "This shows that there are entirely new cancer-causing genes that are going to be discovered through these sequencing efforts."

In half of the study's patients, the researchers found mutations in genes that control two fundamental cellular processes: how RNA is processed and proteins are folded. Two of these genes, DIS3 and FAM46C, appear to play important roles in the stability of RNA and hence its translation into protein. Researchers also found genes involved in blood clotting mutated in multiple myeloma patients, a new and surprising discovery. Follow-up studies will be needed to understand what role these defective genes play in cancer and how they can inform treatment.

"It's going to take a lot of biological research to sort out whether these will make good drug targets," said Golub, "but this is an example of how genetic analysis can help point the field in the right direction very dramatically."

One finding with more immediate clinical importance is the discovery of BRAF mutations in a small number of multiple myeloma patients. BRAF mutations have "never been a part of the multiple myeloma lexicon before," according to Golub, but have been previously seen in other forms of cancer, including melanoma and colon cancer. Drugs are now in clinical development to target this particular gene and have shown promising early results in patients with melanoma.

When the scientists looked at samples from over 150 patients with multiple myeloma, they found BRAF mutations in about four percent of cases. Further studies will be needed to see if drugs that inhibit BRAF are as effective in patients with multiple myeloma as they have been in patients with melanoma.

Golub pointed out that with more samples and the analytical tools to look genome-wide, a new picture of the multiple myeloma genome is beginning to develop, and with it, new genetic insights. "This study shows that there really are entirely new cancer-causing genes that are going to be discovered through these efforts," he said.

### All of the data generated through this project have been made publicly available to cancer researchers worldwide. Funding for this project was provided by the Multiple Myeloma Research Foundation and tissue samples were provided by the Multiple Myeloma Research Consortium tissue bank.

Paper cited: Chapman MA et al. Initial genome sequencing and analysis of multiple myeloma. Nature. March 24, 2011. DOI: 10.1038/nature09965

About the Broad Institute of Harvard and MIT The Eli and Edythe L. Broad Institute of Harvard and MIT was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to http://www.broadinstitute.org.

About Dana-Farber Cancer Institute Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Children's Hospital Boston as Dana-Farber/Children's Hospital Cancer Center. Dana-Farber is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.

For more information, contact:

Broad Institute of MIT and Harvard
Nicole Davis
617.714.7152
ndavis@broadinstitute.org

Dana-Farber Cancer Institute
Bill Schaller
617-632-5357
william_schaller@dfci.harvard.edu


ELSE PRESS RELEASES FROM THIS DATE:

Drug prevents Type 2 diabetes in majority of high-risk individuals

2011-03-24
SAN ANTONIO, Texas, U.S.A. (March 24, 2011) — A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, U.S. scientists reported today. The team also noted a 31 percent decrease in the rate of thickening of the carotid artery, the major vessel that supplies blood to the brain. The study, which enrolled 602 participants through The University of Texas Health Science Center San Antonio and seven collaborating centers, is described in the New ...

Mouse cancer genome unveils genetic errors in human cancers

2011-03-24
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse. By sequencing the genome of a mouse with cancer, researchers at Washington University School of Medicine in St. Louis have uncovered mutations that also drive cancer in humans. The investigators are the first to sequence a mouse cancer genome, and their research is reported online March 23 in the Journal of Clinical Investigation. "This approach gives us a way to rapidly evaluate ...

New insight into how environmental enrichment enhances memory

2011-03-24
It is well established that environmental enrichment, providing animals with rich sensory, motor, and social stimulation, produces both dramatic increases in the number of synapses in the brain and enhanced learning. However, causal relationships between synapse formation and improved memory have not been definitively established. Now, a new study published by Cell Press in the March 24 issue of the journal Neuron introduces a valuable model system for investigating the role of synapse turnover in learning and memory in adult animals and elucidates mechanisms that link ...

The evolution of brain wiring: Navigating to the neocortex

2011-03-24
A new study is providing fascinating insight into how projections conveying sensory information in the brain are guided to their appropriate targets in different species. The research, published by Cell Press in the March 24 issue of the journal Neuron, reveals a surprising new evolutionary scenario that may help to explain how subtle changes in the migration of "guidepost" neurons underlie major differences in brain connectivity between mammals and nonmammalian vertebrates. The neocortex (the "new" cortex) is a brain area that is unique to mammals and plays a central ...

Mass. General study reveals how lung cancers evolve in response to targeted treatment

2011-03-24
A detailed analysis of lung tumors that became resistant to targeted therapy drugs has revealed two previously unreported resistance mechanisms. In a report in the March 23 Science Translational Medicine, investigators from the Massachusetts General Hospital (MGH) Cancer Center also describe how the cellular nature of some tumors actually changes in response to treatment and find that resistance-conferring mutations can disappear after treatment is discontinued. The findings support the importance of monitoring the molecular status of tumors throughout the treatment process. "It ...

Red tape for clinical trial consent can be lethal: Experts

2011-03-24
Current rules requiring researchers to obtain consent for patients to take part in clinical trials in emergency situations are causing life-threatening delays to treatment, experts have argued. They say that in severe trauma cases, waiting for a relative to give written permission is "unethical" because of the importance of prompt treatment. Professor Ian Roberts, Dr Haleema Shakur and Dr David Prieto-Merino, from the Clinical Trials Unit of the London School of Hygiene & Tropical Medicine, make their point in a letter published in The Lancet. It is co-signed by Sir ...

Why salad helps you say yes to 'NO'

2011-03-24
Disorders of the circulatory system- vascular diseases- are common in the developed world, and can lead to heart attacks, strokes and even death. However, treatments for these disorders, such as bypass surgery and angioplasty, themselves induce vascular injury, after which the cells of the blood vessel can over-proliferate in a way that limits blood flow. Nitric oxide (NO) is an important molecule that helps maintain the contractility and health of vascular smooth muscle cells, and multiple studies have linked vascular pathology to a decreased level of NO. Therefore, therapies ...

JCI online early table of contents: March 23, 2011

2011-03-24
EDITOR'S PICK Why salad helps you say yes to NO Disorders of the circulatory system- vascular diseases- are common in the developed world, and can lead to heart attacks, strokes and even death. However, treatments for these disorders, such as bypass surgery and angioplasty, themselves induce vascular injury, after which the cells of the blood vessel can over-proliferate in a way that limits blood flow. Nitric oxide (NO) is an important molecule that helps maintain the contractility and health of vascular smooth muscle cells, and multiple studies have linked vascular ...

When T cells attack: Insight into the mechanism of myocarditis

2011-03-24
Myocardits is an inflammation of the heart muscles that is a major cause of heart failure in young patients. In some cases, the disease is caused by viral infection, but in other patients it is linked to an autoimmune attack on the heart muscle. There are few effective treatment options for myocarditis, in part because the molecular mechanisms that underlie the defect are poorly defined. In this paper, researchers led by Myra Lipes, at the Joslin Diabetes Center in Boston, Massachusetts, used a mouse model of spontaneous myocarditis. They found that the disease occurs ...

Niche Retails Seeks Magento-Based Sites for Free Reviews and Evaluations

Niche Retails Seeks Magento-Based Sites for Free Reviews and Evaluations
2011-03-24
Niche Retail, a Magento Enterprise Solutions Partner, has announced a free review of Magento websites for those who are interested in maximizing customer conversions and in increasing exposure for their site. Specializing in advanced, Magento-based designs for online retail stores, Niche Retail has been developing sites for retail clients with a great deal of success, helping companies drive traffic to their online stores and convert those visits into sales. Now, Niche Retail is offering free exposure to those who have utilized the Magento platform for their business, with ...

LAST 30 PRESS RELEASES:

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

[Press-News.org] First look at the full multiple myeloma genome reveals new insights, discoveries
Sequencing and analysis of nearly 40 tumor genomes points multiple myeloma research in new directions